You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
植耀輝:公布CPI前夕美股回吐 港股250天線附近爭持
耀才證券研究部總監植耀輝稱,隔晚(9日)美股在公布CPI及PPI前夕表現欠佳,三大指數均下跌。當中道指下跌191點或0.54%,標普500指數亦跌0.7%,至於納指跌幅更達到1.2%。 港股昨日則繼續缺乏明確方向,低開125點後曾由跌轉升,最多便曾升86點,逼近19,300點附近,午後則於19,100至19,200點上落,在競價時段恆指升幅稍為擴大,最終恆指上升61點或0.32%,收報19,246點,科指則基本上平收,不過成交量只得約850億元,反映入市態度審慎。A股則連續第三個交易日下跌,上綜指下跌0.5%,深成指亦跌0.53%,兩市成交進一步減少至不足7,400億元人民幣,反映內投資者觀望氣氛仍見濃厚。由於早前公布之進出口數據及PPI、CPI表現亦一般,加上有消息指美國將於短期內公布新一輪限美企投資中國高新科技行業,預期對投資氣氛亦有一定影響,加上繼續觀望大藍籌業績,預期大市將於250天線附近,亦即19,300水平上落。 (筆者為證監會持牌人,並未持有相關股份) ************ 觀望美CPI數據 港股反彈阻力250天線 耀才研究部稱,美股隔晚(9日)下跌,當中納指跌幅超過1%,道指及標普500指數則分別下跌0.54%及0.7%。投資者觀望今晚(10日)公布之CPI數據。至於反映中概股表現之金龍指數跌幅微跌6點,惟已是連跌第四個交易日。 至於港股,昨日呈區間上落。最新公布之7月CPI雖略勝預期,惟-0.3%亦意味內地出現通縮,A股偏軟,連帶港股亦缺乏方向,最終恆指收報19,246點,上升61點或0.32%,科指則微跌不足1點,全日成交金額只得850億元。內房股個別發展,另早前急跌之醫藥股則出現反彈,個別如信達生物(01801.HK)及康希諾(06185.HK)升幅更達到12%及15.5%。投資者繼續關注內地經濟消息及會否有更多政策出台,另外中美關係亦成焦點,預期市況將繼續於現水平附近爭持。 技術走勢方面,恆指昨日中止兩連跌並反彈,惟受制於250天線(約19,300點)阻力,短期仍以此水平作為好淡分水嶺。本輪恆指走勢暫仍呈一浪高於一浪形態,只是成交未見太配合,暫以前低位18,500點為支持。 (筆者為證監會持牌人)~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account